The latest news, views and analysis from the pharmaceutical industry’s frontline in the war on cancer. Updates on pharmaceutical and biotech oncology pipelines, regulatory decisions and market access news, and how healthcare systems needs to change to tackle one of the world’s biggest killers.
Approval by May could put Keytruda in pole position
pharmaphorum media and Symplur, LLC launch Conference360 Report to help pharma and other stakeholders understand social media conversations around medical congresses
Roche faces competition against its blockbuster haematology drug
Checkpoint inhibitor drug set to be fourth competitor in PD-1/PD-L1 market
Leukaemia drug latest cancer treatment to gain NICE approval
Latest approval for Opdivo good news, but won’t make up for lung cancer setback
FDA backs Darzalex in multiple myeloma second line.
NICE says price cut made approval possible, despite continuing uncertainty about benefits